ICRM
MD icon

Insight Capital Research & Management’s Pediatrix Medical MD Stock Holding History

Insight Capital Research & Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-37,188
Closed -$2.86M – 109
2015
Q3 		$2.86M Buy
37,188
+34,428
+1,247% +$2.78M 0.86% 58
2015
Q2 		$205K Sell
2,760
-99
-3% -$7.13K 0.05% 97
2015
Q1 		$207K Buy
+2,859
New +$199K 0.05% 112

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Insight Capital Research & Management's MD Position: Q4 2015 in Review

Insight Capital Research & Management sold out of Pediatrix Medical (MD) in Q4 2015, closing a stake of 37,188 shares — an estimated $2.86M sold.

Insight Capital Research & Management first reported a position in MD in Q1 2015 and held it in 3 quarters. The position peaked at $2.86M in Q3 2015. 399 funds tracked by Wall St. Rank hold MD as of Q4 2015.

  • Insight Capital Research & Management reported no remaining Pediatrix Medical position as of Q4 2015 after selling out during the quarter.
  • Insight Capital Research & Management sold 37,188 Pediatrix Medical shares in Q4 2015, an estimated $2.86M.
  • Insight Capital Research & Management first reported a position in Pediatrix Medical in Q1 2015 and held it in 3 quarters.
  • Insight Capital Research & Management's Pediatrix Medical position peaked at $2.86M in Q3 2015.
  • 399 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2015.

Based on Insight Capital Research & Management's 13F filing for Q4 2015, filed 8 Feb 2016.